Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

Verney A, Traverse-Glehen A, Callet-Bauchu E, Jallades L, Magaud JP, Salles G, Genestier L, Baseggio L.

Oncotarget. 2018 May 4;9(34):23589-23598. doi: 10.18632/oncotarget.25283. eCollection 2018 May 4.

2.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A.

Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.

3.

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Tesson B, Huet S, Grange B, Jallades L, Baseggio L, Felman P, Traverse-Glehen A, Magaud JP, Lega JC, Bole-Feysot C, Salles G, Callet-Bauchu E, Sujobert P.

Blood. 2017 Sep 7;130(10):1267-1269. doi: 10.1182/blood-2017-03-776674. Epub 2017 Jul 5. No abstract available.

4.

The ibrutinib B-cell proliferation inhibition is potentiated in vitro by dexamethasone: Application to chronic lymphocytic leukemia.

Manzoni D, Catallo R, Chebel A, Baseggio L, Michallet AS, Roualdes O, Magaud JP, Salles G, Ffrench M.

Leuk Res. 2016 Aug;47:1-7. doi: 10.1016/j.leukres.2016.05.003. Epub 2016 May 10.

PMID:
27235717
5.

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.

Mestrallet F, Sujobert P, Sarkozy C, Traverse-Glehen A, Callet-Bauchu E, Magaud JP, Salles G, Baseggio L.

Cytometry B Clin Cytom. 2016 Sep;90(5):433-9. doi: 10.1002/cyto.b.21331. Epub 2015 Dec 11.

6.

Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts.

Huet S, Dulucq S, Chauveau A, Ménard A, Chomel JC, Maisonneuve H, Legros L, Perrin MC, Ferrant E, Moreilhon C, Couturier MA, Sujobert P, Magaud JP, Ugo V, Chabane K, Raynaud S, Hayette S; GBMHM (Groupe des Biologistes Moléculaires des Hémopathies Malignes, French Molecular Biology Group in Hematology).

Genes Chromosomes Cancer. 2015 Oct;54(10):595-605. doi: 10.1002/gcc.22263. Epub 2015 Aug 7.

PMID:
26252834
7.

Major molecular response achievement in CML Patients can be predicted by BCR-ABL1/ABL1 or BCR-ABL1/GUS ratio at an earlier time point of follow-up than currently recommended.

Huet S, Cony-Makhoul P, Heiblig M, Tigaud I, Gazzo S, Belhabri A, Souche D, Michallet M, Magaud JP, Hayette S, Nicolini F.

PLoS One. 2014 Sep 9;9(9):e106250. doi: 10.1371/journal.pone.0106250. eCollection 2014.

8.

Alarms and parameters generated by hematology analyzer: new tools to predict and quantify circulating Sezary cells.

Brisou G, Manzoni D, Dalle S, Felman P, Morel D, Boubaya M, Magaud JP, Baseggio L.

J Clin Lab Anal. 2015 Mar;29(2):153-61. doi: 10.1002/jcla.21744. Epub 2014 Mar 20.

PMID:
24652675
9.

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia.

Huet S, Jallades L, Charlot C, Chabane K, Nicolini FE, Michallet M, Magaud JP, Hayette S.

Leuk Res Treatment. 2013;2013:756703. doi: 10.1155/2013/756703. Epub 2013 Apr 9.

10.

Pertinence of the Sysmex XE-5000™ parameters: rule of slide review in a context of 'normal' lymphocyte count (defined from control and mantle cell lymphoma blood specimens).

Chhuy J, Morel D, Goeddert G, Magaud JP, Felman P, Baseggio L.

Int J Lab Hematol. 2013 Oct;35(5):510-6. doi: 10.1111/ijlh.12042. Epub 2012 Dec 27.

PMID:
23279807
11.

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.

Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, Huet S, Renneville A, Salles G, Nicolini FE, Magaud JP, Michallet M.

PLoS One. 2012;7(12):e51527. doi: 10.1371/journal.pone.0051527. Epub 2012 Dec 10.

12.

In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.

Baseggio L, Geay MO, Gazzo S, Berger F, Traverse-Glehen A, Ffrench M, Hayette S, Callet-Bauchu E, Verney A, Morel D, Jallades L, Magaud JP, Salles G, Felman P.

Br J Haematol. 2012 Aug;158(4):489-98. doi: 10.1111/j.1365-2141.2012.09178.x. Epub 2012 Jun 12.

PMID:
22686190
13.

[Surgical risk of transfusion in a French Universitary Hospital].

Puel C, Ducharne T, Mialon A, Augey L, Repellin L, Corond P, Magaud JP, Piriou V.

Ann Fr Anesth Reanim. 2012 Feb;31(2):132-40. doi: 10.1016/j.annfar.2011.10.027. Epub 2012 Jan 26. French.

PMID:
22281232
14.

MicroRNA expression profile in splenic marginal zone lymphoma.

Bouteloup M, Verney A, Rachinel N, Callet-Bauchu E, Ffrench M, Coiffier B, Magaud JP, Berger F, Salles GA, Traverse-Glehen A.

Br J Haematol. 2012 Jan;156(2):279-81. doi: 10.1111/j.1365-2141.2011.08848.x. Epub 2011 Sep 9. No abstract available.

PMID:
21902683
15.

CD10 and ICOS expression by multiparametric flow cytometry in angioimmunoblastic T-cell lymphoma.

Baseggio L, Traverse-Glehen A, Berger F, Ffrench M, Jallades L, Morel D, Goedert G, Magaud JP, Salles G, Felman P.

Mod Pathol. 2011 Jul;24(7):993-1003. doi: 10.1038/modpathol.2011.53. Epub 2011 Apr 15.

16.

Cyclin-dependent kinase 1 expression is inhibited by p16(INK4a) at the post-transcriptional level through the microRNA pathway.

Chien WW, Domenech C, Catallo R, Kaddar T, Magaud JP, Salles G, Ffrench M.

Oncogene. 2011 Apr 21;30(16):1880-91. doi: 10.1038/onc.2010.570. Epub 2010 Dec 20.

PMID:
21170085
17.

The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge.

Nicolini FE, Chomel JC, Roy L, Legros L, Chabane K, Ducastelle S, Nicolas-Virelizier E, Michallet M, Tigaud I, Magaud JP, Turhan A, Guilhot F, Hayette S.

Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):394-9. doi: 10.3816/CLML.2010.n.073.

PMID:
21030353
18.

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).

Baseggio L, Traverse-Glehen A, Callet-Bauchu E, Morel D, Magaud JP, Berger F, Salles G, Felman P.

Hematol Oncol. 2011 Mar;29(1):47-51. doi: 10.1002/hon.957.

PMID:
20677173
19.

Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients.

Hayette S, Chabane K, Michallet M, Michallat E, Cony-Makhoul P, Salesse S, Maguer-Satta V, Magaud JP, Nicolini FE.

Leuk Res. 2011 Jan;35(1):38-43. doi: 10.1016/j.leukres.2010.06.030. Epub 2010 Jul 29.

PMID:
20673586
20.

Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone.

Nicolini FE, Hayette S, Legros L, Rousselot P, Maloisel F, Tulliez M, Guerci A, Charbonnier A, Prébet T, Rigal-Huguet F, Chabane K, Magaud JP, Paillet C, Pivot C, Michallet M.

Leuk Res. 2011 Jan;35(1):80-6. doi: 10.1016/j.leukres.2010.04.010. Epub 2010 Jun 3.

PMID:
20605207
21.

Two new miR-16 targets: caprin-1 and HMGA1, proteins implicated in cell proliferation.

Kaddar T, Rouault JP, Chien WW, Chebel A, Gadoux M, Salles G, Ffrench M, Magaud JP.

Biol Cell. 2009 Sep;101(9):511-24. doi: 10.1042/BC20080213.

PMID:
19250063
22.

Prognostic value of miR-16 expression in childhood acute lymphoblastic leukemia relationships to normal and malignant lymphocyte proliferation.

Kaddar T, Chien WW, Bertrand Y, Pages MP, Rouault JP, Salles G, Ffrench M, Magaud JP.

Leuk Res. 2009 Sep;33(9):1217-23. doi: 10.1016/j.leukres.2008.12.015. Epub 2009 Feb 4.

PMID:
19195700
23.

Emergence of therapy-unrelated CML on a background of BCR-ABL-negative JAK2V617F-positive chronic idiopathic myelofibrosis.

Jallades L, Hayette S, Tigaud I, Johnston A, Coiffier B, Magaud JP, Ffrench M.

Leuk Res. 2008 Oct;32(10):1608-10. doi: 10.1016/j.leukres.2008.03.004. Epub 2008 Apr 29.

PMID:
18448166
24.

Splenic red pulp lymphoma with numerous basophilic villous lymphocytes: a distinct clinicopathologic and molecular entity?

Traverse-Glehen A, Baseggio L, Bauchu EC, Morel D, Gazzo S, Ffrench M, Verney A, Rolland D, Thieblemont C, Magaud JP, Salles G, Coiffier B, Berger F, Felman P.

Blood. 2008 Feb 15;111(4):2253-60. Epub 2007 Nov 27.

25.

Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma.

Gazzo S, Chudoba I, Traverse-Glehen A, Baseggio L, Felman P, Berger F, Salles G, Hayette S, Magaud JP, Callet-Bauchu E.

Cancer Genet Cytogenet. 2007 Jun;175(2):159-65.

PMID:
17556073
26.

BCR-ABL(T315I) transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge?

Legros L, Hayette S, Nicolini FE, Raynaud S, Chabane K, Magaud JP, Cassuto JP, Michallet M.

Leukemia. 2007 Oct;21(10):2204-6. Epub 2007 May 31. No abstract available.

PMID:
17541396
27.

Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.

Traverse-Glehen A, Verney A, Baseggio L, Felman P, Callet-Bauchu E, Thieblemont C, Ffrench M, Magaud JP, Coiffier B, Berger F, Salles G.

Leukemia. 2007 Aug;21(8):1821-4. Epub 2007 May 3. No abstract available.

PMID:
17476282
28.

BCR-ABL mutant kinetics in CML patients treated with dasatinib.

Nicolini FE, Chabane K, Tigaud I, Michallet M, Magaud JP, Hayette S.

Leuk Res. 2007 Jun;31(6):865-8. Epub 2007 Jan 8.

PMID:
17208297
29.

The expression of TCR-gamma delta/CD3 complex in neoplastic gamma delta T-cell.

Baseggio L, Berger F, Monneret G, Magaud JP, Salles G, Felman P.

Haematologica. 2006 Dec;91(12):1717-9.

30.

Identification of circulating CD10 positive T cells in angioimmunoblastic T-cell lymphoma.

Baseggio L, Berger F, Morel D, Delfau-Larue MH, Goedert G, Salles G, Magaud JP, Felman P.

Leukemia. 2006 Feb;20(2):296-303.

PMID:
16341050
31.

Atypical cytogenetic presentation of t(11;14) in mantle cell lymphoma.

Gazzo S, Felman P, Berger F, Salles G, Magaud JP, Callet-Bauchu E.

Haematologica. 2005 Dec;90(12):1708-9.

32.

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib.

Cayuela JM, Rousselot P, Nicolini F, Espinouse D, Ollagnier C, Bui-Thi MH, Chabane K, Raffoux E, Callet-Bauchu E, Tigaud I, Magaud JP, Hayette S.

Leukemia. 2005 Dec;19(12):2334-6. No abstract available.

PMID:
16224485
33.

An unusual case of indolent B-cell lymphoma with distinct chronic lymphocytic leukemia and marginal zone differentiation according to the site of involvement.

Baseggio L, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Thieblemont C, Bryon PA, Magaud JP, Berger F, Felman P.

Leuk Lymphoma. 2005 Sep;46(9):1369-74.

PMID:
16109617
34.

Cytogenetic analysis delineates a spectrum of chromosomal changes that can distinguish non-MALT marginal zone B-cell lymphomas among mature B-cell entities: a description of 103 cases.

Callet-Bauchu E, Baseggio L, Felman P, Traverse-Glehen A, Berger F, Morel D, Gazzo S, Poncet C, Thieblemont C, Coiffier B, Magaud JP, Salles G.

Leukemia. 2005 Oct;19(10):1818-23.

PMID:
16094418
35.

AF4p12, a human homologue to the furry gene of Drosophila, as a novel MLL fusion partner.

Hayette S, Cornillet-Lefebvre P, Tigaud I, Struski S, Forissier S, Berchet A, Doll D, Gillot L, Brahim W, Delabesse E, Magaud JP, Rimokh R.

Cancer Res. 2005 Aug 1;65(15):6521-5.

36.

Assessment and follow-up of the proportion of T315I mutant BCR-ABL transcripts can guide appropriate therapeutic decision making in CML patients.

Hayette S, Michallet M, Baille ML, Magaud JP, Nicolini FE.

Leuk Res. 2005 Sep;29(9):1073-7. Epub 2005 Mar 23.

PMID:
16038734
37.

Clinicopathologic features of Waldenstrom's macroglobulinemia and marginal zone lymphoma: are they distinct or the same entity?

Berger F, Traverse-Glehen A, Felman P, Callet-Bauchu E, Baseggio L, Gazzo S, Thieblemont C, Ffrench M, Magaud JP, Salles G, Coiffer B.

Clin Lymphoma. 2005 Mar;5(4):220-4. Review.

PMID:
15794852
38.

Identification of a rare e6a2 BCR-ABL fusion gene during the disease progression of chronic myelomonocytic leukemia: a case report.

Hayette S, Tigaud I, Thomas X, French M, Perrin MC, Nicolini F, Michallet M, Magaud JP.

Leukemia. 2004 Oct;18(10):1735-6. No abstract available.

PMID:
15356652
39.

CCR4-associated factor CAF1 is an essential factor for spermatogenesis.

Berthet C, Morera AM, Asensio MJ, Chauvin MA, Morel AP, Dijoud F, Magaud JP, Durand P, Rouault JP.

Mol Cell Biol. 2004 Jul;24(13):5808-20.

40.

Autolysosomes accumulate during in vitro CD8+ T-lymphocyte aging and may participate in induced death sensitization of senescent cells.

Gerland LM, Genestier L, Peyrol S, Michallet MC, Hayette S, Urbanowicz I, Ffrench P, Magaud JP, Ffrench M.

Exp Gerontol. 2004 May;39(5):789-800.

PMID:
15130673
41.

Secondary Philadelphia chromosome after non-myeloablative peripheral blood stem cell transplantation for a myelodysplastic syndrome in transformation.

Prebet T, Michallet AS, Charrin C, Hayette S, Magaud JP, Thiébaut A, Michallet M, Nicolini FE.

Bone Marrow Transplant. 2004 Jan;33(2):247-9. No abstract available.

PMID:
14716291
42.

Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging.

Gerland LM, Peyrol S, Lallemand C, Branche R, Magaud JP, Ffrench M.

Exp Gerontol. 2003 Aug;38(8):887-95.

PMID:
12915210
43.

In B-cell chronic lymphocytic leukemias, 7q21 translocations lead to overexpression of the CDK6 gene.

Hayette S, Tigaud I, Callet-Bauchu E, Ffrench M, Gazzo S, Wahbi K, Callanan M, Felman P, Dumontet C, Magaud JP, Rimokh R.

Blood. 2003 Aug 15;102(4):1549-50. No abstract available.

44.

CDK2 is involved in the S-phase lengthening induced by glucocorticoids in normal human lymphocytes.

Peiretti A, Baghdassarian N, Gerland LM, Ffrench P, Bryon PA, Magaud JP, Ffrench M.

Eur J Cell Biol. 2003 May;82(5):253-61.

PMID:
12800980
45.

Regulation of human erythropoiesis by activin A, BMP2, and BMP4, members of the TGFbeta family.

Maguer-Satta V, Bartholin L, Jeanpierre S, Ffrench M, Martel S, Magaud JP, Rimokh R.

Exp Cell Res. 2003 Jan 15;282(2):110-20.

PMID:
12531697
46.

Recurrent involvement of the MLL gene in adult T-lineage acute lymphoblastic leukemia.

Hayette S, Tigaud I, Maguer-Satta V, Bartholin L, Thomas X, Charrin C, Gadoux M, Magaud JP, Rimokh R.

Blood. 2002 Jun 15;99(12):4647-9. No abstract available.

47.

Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features.

Charrin C, Belhabri A, Treille-Ritouet D, Theuil G, Magaud JP, Fiere D, Thomas X.

Hematol J. 2002;3(1):21-31.

PMID:
11960392
48.

Transcription activation of FLRG and follistatin by activin A, through Smad proteins, participates in a negative feedback loop to modulate activin A function.

Bartholin L, Maguer-Satta V, Hayette S, Martel S, Gadoux M, Corbo L, Magaud JP, Rimokh R.

Oncogene. 2002 Mar 28;21(14):2227-35.

49.

Interaction of PRMT1 with BTG/TOB proteins in cell signalling: molecular analysis and functional aspects.

Berthet C, Guéhenneux F, Revol V, Samarut C, Lukaszewicz A, Dehay C, Dumontet C, Magaud JP, Rouault JP.

Genes Cells. 2002 Jan;7(1):29-39.

50.

Coding region of the sorbin gene in different species.

Wahbi K, Magaud JP, Pansu D, Descroix-Vagne M.

Peptides. 2001 Dec;22(12):2045-53.

PMID:
11786189

Supplemental Content

Loading ...
Support Center